JP2024543248A5 - - Google Patents

Info

Publication number
JP2024543248A5
JP2024543248A5 JP2024527321A JP2024527321A JP2024543248A5 JP 2024543248 A5 JP2024543248 A5 JP 2024543248A5 JP 2024527321 A JP2024527321 A JP 2024527321A JP 2024527321 A JP2024527321 A JP 2024527321A JP 2024543248 A5 JP2024543248 A5 JP 2024543248A5
Authority
JP
Japan
Application number
JP2024527321A
Other languages
Japanese (ja)
Other versions
JPWO2023086815A5 (https=
JP2024543248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/079533 external-priority patent/WO2023086815A1/en
Publication of JP2024543248A publication Critical patent/JP2024543248A/ja
Publication of JPWO2023086815A5 publication Critical patent/JPWO2023086815A5/ja
Publication of JP2024543248A5 publication Critical patent/JP2024543248A5/ja
Pending legal-status Critical Current

Links

JP2024527321A 2021-11-10 2022-11-09 トランスジェニック哺乳動物およびその使用方法 Pending JP2024543248A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163263855P 2021-11-10 2021-11-10
US63/263,855 2021-11-10
PCT/US2022/079533 WO2023086815A1 (en) 2021-11-10 2022-11-09 Transgenic mammals and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2024543248A JP2024543248A (ja) 2024-11-20
JPWO2023086815A5 JPWO2023086815A5 (https=) 2025-11-17
JP2024543248A5 true JP2024543248A5 (https=) 2025-11-17

Family

ID=84519373

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024527321A Pending JP2024543248A (ja) 2021-11-10 2022-11-09 トランスジェニック哺乳動物およびその使用方法

Country Status (9)

Country Link
US (1) US20240423175A1 (https=)
EP (1) EP4429456A1 (https=)
JP (1) JP2024543248A (https=)
KR (1) KR20240110577A (https=)
CN (1) CN118265449A (https=)
AU (1) AU2022386319A1 (https=)
CA (1) CA3235395A1 (https=)
IL (1) IL312359A (https=)
WO (1) WO2023086815A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202209247D0 (en) * 2022-06-23 2022-08-10 Petmedix Ltd Animal models and therapeutic molecules

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
GB8904009D0 (en) 1989-02-22 1989-04-05 Celltech Ltd Vector
US5464764A (en) 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US6689610B1 (en) 1989-08-22 2004-02-10 University Of Utah Research Foundation Cells and non-human organisms containing predetermined genomic modifications and positive-negative selection methods and vectors for making same
US6673986B1 (en) 1990-01-12 2004-01-06 Abgenix, Inc. Generation of xenogeneic antibodies
US5877397A (en) 1990-08-29 1999-03-02 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US7041871B1 (en) 1995-10-10 2006-05-09 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
ATE352612T1 (de) 1990-08-29 2007-02-15 Pharming Intellectual Pty Bv Homologe rekombination in säugetier-zellen
US5789650A (en) 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5874299A (en) 1990-08-29 1999-02-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
DE4228162C1 (de) 1992-08-25 1994-01-13 Rajewsky Klaus Dr Verfahren zum Ersetzen homologer Genabschnitte aus Säugern in der Keimbahn von nicht-menschlichen Säugern
US5593598A (en) 1994-04-20 1997-01-14 Mcginness; Michael P. Method and apparatus for closed loop recycling of contaminated cleaning solution
US6130364A (en) 1995-03-29 2000-10-10 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
US6091001A (en) 1995-03-29 2000-07-18 Abgenix, Inc. Production of antibodies using Cre-mediated site-specific recombination
EP1500329B1 (en) 1996-12-03 2012-03-21 Amgen Fremont Inc. Human antibodies that specifically bind human TNF alpha
US6774279B2 (en) 1997-05-30 2004-08-10 Carnegie Institution Of Washington Use of FLP recombinase in mice
FR2814642B1 (fr) 2000-10-03 2005-07-01 Ass Pour Le Dev De La Rech En Souris transgenique pour la recombinaison ciblee mediee par la cre-er modifiee
US6596541B2 (en) 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US7422889B2 (en) 2004-10-29 2008-09-09 Stowers Institute For Medical Research Dre recombinase and recombinase systems employing Dre recombinase
US10662256B2 (en) * 2010-07-26 2020-05-26 Trianni, Inc. Transgenic mammals and methods of use thereof
US20170058052A1 (en) 2015-08-24 2017-03-02 Trianni, Inc. Enhanced production of immunoglobulins
WO2018128691A1 (en) * 2016-11-04 2018-07-12 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered immunoglobulin lambda light chain locus
GB2561352B (en) * 2017-04-10 2023-01-18 Genome Res Ltd Animal models and therapeutic molecules
GB2578867A (en) * 2018-10-09 2020-06-03 Genome Res Ltd Animal models and therapeutic molecules
CA3144956A1 (en) * 2019-07-01 2021-01-07 Trianni, Inc. Transgenic mammals and methods of use
WO2021003152A1 (en) * 2019-07-01 2021-01-07 Trianni, Inc. Transgenic mammals and methods of use thereof

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
JP2024516996A5 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR102022023461A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13149U (https=)
BY13160U (https=)
BY13141U (https=)
BY13142U (https=)
BY13143U (https=)
BY13144U (https=)
BY13145U (https=)
BY13166U (https=)